Patent · US Active

Corneal denervation for treatment of ocular pain

US10596038B2 · kind B2 · utility

2Cited by
263References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2017
Grant dateMar 24, 2020
Priority date
Expiry dateMay 10, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N7/02
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and apparatus for the treatment of the eye to reduce pain can treat at least an outer region of the tissue so as to denervate nerves extending into the inner region and reduce the pain. For example, the cornea of the eye may comprise an inner region having an epithelial defect, and an outer portion of the cornea can be treated to reduce pain of the epithelial defect. The outer portion of the cornea can be treated to denervate nerves extending from the outer portion to the inner portion. The outer portion can be treated in many ways to denervate the nerve, for example with one or more of heat, cold or a denervating noxious substance such as capsaicin. The denervation of the nerve can be reversible, such that corneal innervation can return following treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.